235 related articles for article (PubMed ID: 9731500)
21. Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel.
Schuette W; Nagel S; Blankenburg T; Lautenschlaeger C; Hans K; Schmidt EW; Dittrich I; Schweisfurth H; von Weikersthal LF; Raghavachar A; Reissig A; Serke M
J Clin Oncol; 2005 Nov; 23(33):8389-95. PubMed ID: 16293869
[TBL] [Abstract][Full Text] [Related]
22. Weekly schedules of docetaxel.
Burris H
Semin Oncol; 1998 Dec; 25(6 Suppl 13):21-3. PubMed ID: 9865688
[TBL] [Abstract][Full Text] [Related]
23. Circadian variation of Valproic acid pharmacokinetics in mice.
Ben-Cherif W; Dridi I; Aouam K; Ben-Attia M; Reinberg A; Boughattas NA
Eur J Pharm Sci; 2013 Jul; 49(4):468-73. PubMed ID: 23707469
[TBL] [Abstract][Full Text] [Related]
24. Circadian rhythm in toxic effects of cystemustine in mice: relevance for chronomodulated delivery.
Martineau-Pivoteau N; Levi F; Rolhion C; Kwiatkowski F; Lemaigre G; Filipski E; Chollet P
Int J Cancer; 1996 Nov; 68(5):669-74. PubMed ID: 8938151
[TBL] [Abstract][Full Text] [Related]
25. Circadian time dependence of murine tolerance for carboplatin.
Boughattas NA; Lévi F; Hecquet B; Lemaigre G; Roulon A; Fournier C; Reinberg A
Toxicol Appl Pharmacol; 1988 Nov; 96(2):233-47. PubMed ID: 3057682
[TBL] [Abstract][Full Text] [Related]
26. Circadian variations in myelosuppressive activity of interferon-alpha in mice: identification of an optimal treatment time associated with reduced myelosuppressive activity.
Koren S; Fleischmann WR
Exp Hematol; 1993 Apr; 21(4):552-9. PubMed ID: 8462664
[TBL] [Abstract][Full Text] [Related]
27. Circadian disruption accelerates liver carcinogenesis in mice.
Filipski E; Subramanian P; Carrière J; Guettier C; Barbason H; Lévi F
Mutat Res; 2009; 680(1-2):95-105. PubMed ID: 19833225
[TBL] [Abstract][Full Text] [Related]
28. Circadian time-effect of orally administered loratadine on plasma pharmacokinetics in mice.
Dridi D; Ben-Attia M; Sani M; Djebli N; Sauvage FL; Boughattas NA
Chronobiol Int; 2008 Jul; 25(4):533-47. PubMed ID: 18622814
[TBL] [Abstract][Full Text] [Related]
29. Seasonal modulation of the 8-and 24-hour rhythms of ondansetron tolerance in mice.
Khedhaier A; Ben-Attia M; Gadacha W; Sani M; Reinberg A; Boughattas NA
Chronobiol Int; 2007; 24(6):1199-212. PubMed ID: 18075807
[TBL] [Abstract][Full Text] [Related]
30. Docetaxel enhances tumor radioresponse in vivo.
Mason KA; Hunter NR; Milas M; Abbruzzese JL; Milas L
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2431-8. PubMed ID: 9815644
[TBL] [Abstract][Full Text] [Related]
31. Is weekly docetaxel an active and gentle chemotherapy in the treatment of metastatic breast cancer?
Maisano R; Mare M; Zavettieri M; Caristi N; Mesiti M; Scisca C; La Torre F
Anticancer Res; 2003; 23(2C):1923-6. PubMed ID: 12820480
[TBL] [Abstract][Full Text] [Related]
32. Circadian time dependence of murine tolerance for the alkylating agent peptichemio.
Levi F; Horvath C; Mechkouri M; Roulon A; Bailleul F; Lemaigre G; Reinberg A; Mathe G
Eur J Cancer Clin Oncol; 1987 May; 23(5):487-97. PubMed ID: 3653173
[TBL] [Abstract][Full Text] [Related]
33. Circadian changes in mitoxantrone toxicity in mice: relationship with plasma pharmacokinetics.
Lévi F; Tampellini M; Metzger G; Bizi E; Lemaigre G; Hallek M
Int J Cancer; 1994 Nov; 59(4):543-7. PubMed ID: 7960225
[TBL] [Abstract][Full Text] [Related]
34. Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.
Bissery MC; Vrignaud P; Lavelle F; Chabot GG
Anticancer Drugs; 1996 Jun; 7(4):437-60. PubMed ID: 8826613
[TBL] [Abstract][Full Text] [Related]
35. [Rhythm of expression of BCL-2 protein of MA13/C mammaryadenocarcinoma bearing-mice].
Granda TG; Filipski E; Vrignaud P; Bissery MC; Lévi F
Pathol Biol (Paris); 2003 Jun; 51(4):220-1. PubMed ID: 12852995
[TBL] [Abstract][Full Text] [Related]
36. Circadian variation of isoniazid pharmacokinetics in mice.
Souayed N; Chennoufi M; Frej NB; Chaabane A; Ben-Attia M; Aouam K; Reinberg A; Boughattas NA
Biomed Pharmacother; 2016 Dec; 84():1150-1155. PubMed ID: 27780145
[TBL] [Abstract][Full Text] [Related]
37. Practical aspects of weekly docetaxel administration schedules.
Hainsworth JD
Oncologist; 2004; 9(5):538-45. PubMed ID: 15477638
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological modulation of cisplatin toxicity rhythms with buthionine sulfoximine in mice bearing pancreatic adenocarcinoma (PO3).
Li XM; Filipski E; Lévi F
Chronobiol Int; 1998 Jul; 15(4):323-35. PubMed ID: 9706410
[TBL] [Abstract][Full Text] [Related]
39. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
Braakhuis BJ; Hill BT; Dietel M; Kelland LR; Aapro MS; Zoli W; Lelieveld P
Anticancer Res; 1994; 14(1A):205-8. PubMed ID: 7909419
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological effects of vinorelbine on body temperature and locomotor activity circadian rhythms in mice.
Li XM; Vincenti M; Lévi F
Chronobiol Int; 2002 Jan; 19(1):43-55. PubMed ID: 11962685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
